Maverick Health will be able to scale rapid Point-of-Care (POC) monitoring to their clients as a result of the collaboration, helping them to help organizations catch asymptomatic cases, provide a safer atmosphere for workers, and make neighborhoods as secure as possible.
FREMONT, CA: ixlayer, a pioneer in technology-based diagnostic testing solutions, has been chosen by Maverick Health to offer the information technology infrastructure for their COVID-19 testing program across the United States. Maverick Health will be able to scale rapid Point-of-Care (POC) monitoring to their clients as a result of the collaboration, helping them to help organizations catch asymptomatic cases, provide a safer atmosphere for workers, and make neighborhoods as secure as possible.
“Providing the right solutions for organizations to launch quick, effective programs to offer testing is at the core of our business,” said Pouria Sanae, CEO, ixlayer. “We are pleased to work with Maverick Health to be the backbone of their testing platform as they serve hundreds of organizations and tens of thousands of individuals across the country.”
Maverick Health’s relationship with ixlayer guarantees that POC testing for COVID-19 meets all regulatory criteria. POC testing has the benefit of offering quick outcomes for care and infection prevention decisions, and it is a tried and tested method of evaluating a large number of individuals easily and efficiently. Maverick can easily handle kit delivery and sample selection, patient management, and physician collaboration through ixlayer’s cloud environment, HIPAA, and GDPR compliance.
“As Maverick Health rapidly expands our diagnostic testing capabilities through public private partnerships, concierge testing sites, and in-home testing services were excited to add ixlayer to our suite of solutions,” said Deena Klein, Director of Operations, Maverick Health. “Their strong capabilities make them an obvious provider to supplement our end-to-end solution used by thousands of people each day in search of quick, convenient, and accurate test results.”
The ixlayer COVID-19 Clinical Testing platform collects real-time data, such as demographics on positive and negative tests by age, gender, and geographic location, to quickly spot disease transmission patterns and hotspots. As the number of COVID-19 cases rises and new mutations are found, it is important to keep track of this vital data. As officials keep track of who has been vaccinated, the ixlayers platform is designed to help patient registration, inventory management, scheduling, and public health outreach as vaccinations are distributed. For both companies and individuals, ixlayers software currently supports the production of 50,000 daily tests.